| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 0 | 18.064 | 2.373 | 9.083 | 702 | 0 | 0 |
| Total Income - EUR | - | - | - | 0 | 28.306 | 10.704 | 11.095 | 702 | 0 | 0 |
| Total Expenses - EUR | - | - | - | 2 | 16.602 | 23.008 | 16.511 | 17 | 0 | 0 |
| Gross Profit/Loss - EUR | - | - | - | -2 | 11.704 | -12.303 | -5.417 | 684 | 0 | 0 |
| Net Profit/Loss - EUR | - | - | - | -2 | 11.523 | -12.326 | -5.596 | 663 | 0 | 0 |
| Employees | - | - | - | 0 | 1 | 2 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Oxigen Suits S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 0 | 6.533 | 26.976 | 20.382 | 20.446 | 20.384 | 20.270 |
| Current Assets | - | - | - | 49.009 | 47.220 | 5.225 | 9 | 4 | 4 | 4 |
| Inventories | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | 38.266 | 0 | 0 | 0 | 3 | 3 | 3 |
| Cash | - | - | - | 10.742 | 47.220 | 5.225 | 9 | 1 | 1 | 1 |
| Shareholders Funds | - | - | - | 10.742 | 24.102 | 11.319 | 5.471 | 6.151 | 6.133 | 6.099 |
| Social Capital | - | - | - | 10.745 | 12.581 | 12.342 | 12.068 | 12.106 | 12.069 | 12.002 |
| Debts | - | - | - | 0 | 2.368 | 1.692 | 14.920 | 14.424 | 14.380 | 14.300 |
| Income in Advance | - | - | - | 38.266 | 27.283 | 19.189 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "5510 - 5510" | |||||||||
| CAEN Financial Year |
5510
|
|||||||||
Comments - Oxigen Suits S.r.l.